BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 3036156)

  • 1. Beta 1-adrenergic selectivity of the new cardiotonic agent denopamine in its stimulating effects on adenylate cyclase.
    Inamasu M; Totsuka T; Ikeo T; Nagao T; Takeyama S
    Biochem Pharmacol; 1987 Jun; 36(12):1947-54. PubMed ID: 3036156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On minimum cyclic AMP formation rates associated with positive inotropic effects mediated through beta 1-adrenoceptors in kitten myocardium. Beta 1-specific and non-adrenergic stimulant effects of denopamine.
    Lemoine H; Teng KJ; Slee SJ; Kaumann AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1989; 339(1-2):113-28. PubMed ID: 2566921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of denopamine on the phosphorylation of cardiac muscle proteins in the perfused guinea-pig heart. Comparison with isoproterenol.
    Sasaki Y; Yabana H; Nagao T; Takeyama S
    Biochem Pharmacol; 1988 Feb; 37(4):679-86. PubMed ID: 2829921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Details of mode and mechanism of action of denopamine, a new orally active cardiotonic agent with affinity for beta 1-receptors.
    Yokoyama H; Yanagisawa T; Taira N
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):323-31. PubMed ID: 2464105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of celiprolol (REV 5320), a new cardioselective beta-adrenoceptor antagonist, on in vitro adenylate cyclase, alpha- and beta-adrenergic receptor binding and lipolysis.
    Van Inwegen RG; Khandwala A; Weinryb I; Pruss TP; Neiss E; Sutherland CA
    Arch Int Pharmacodyn Ther; 1984 Nov; 272(1):40-55. PubMed ID: 6151380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of the age-related decrease of epinephrine-stimulated lipolysis in isolated rat adipocytes: beta-adrenergic receptor binding, adenylate cyclase activity, and cyclic AMP accumulation.
    Dax EM; Partilla JS; Gregerman RI
    J Lipid Res; 1981 Aug; 22(6):934-43. PubMed ID: 6268727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta 1- and beta 2-adrenergic receptor-mediated adenylate cyclase stimulation in nonfailing and failing human ventricular myocardium.
    Bristow MR; Hershberger RE; Port JD; Minobe W; Rasmussen R
    Mol Pharmacol; 1989 Mar; 35(3):295-303. PubMed ID: 2564629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Denopamine, a beta(1)-adrenergic agonist, increases alveolar fluid clearance in ex vivo rat and guinea pig lungs.
    Sakuma T; Tuchihara C; Ishigaki M; Osanai K; Nambu Y; Toga H; Takahashi K; Ohya N; Kurihara T; Matthay MA
    J Appl Physiol (1985); 2001 Jan; 90(1):10-6. PubMed ID: 11133887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forskolin as an activator of cyclic AMP accumulation and lipolysis in rat adipocytes.
    Litosch I; Hudson TH; Mills I; Li SY; Fain JN
    Mol Pharmacol; 1982 Jul; 22(1):109-15. PubMed ID: 6289066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin stimulation of cyclic AMP phosphodiesterase is independent from the G-protein pathways involved in adenylate cyclase regulation.
    Weber HW; Chung FZ; Day K; Appleman MM
    J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(5):345-54. PubMed ID: 3040818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of isoprenaline and phenylephrine on the adenosine 3',5'-monophosphate content and mechanical activity of cold-stored and fresh taenia caecum from the guinea-pig.
    Honda F; Katsuki S; Miyahara JT; Shibata S
    Br J Pharmacol; 1977 Aug; 60(4):529-36. PubMed ID: 198053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of experimental insulin-dependent diabetes on the beta-adrenergic-receptor-coupled adenylate-cyclase system and lipolysis in fat cells of the rat.
    Lacasa D; Agli B; Giudicelli Y
    Eur J Biochem; 1983 Feb; 130(3):457-64. PubMed ID: 6297906
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of adrenergic agents on alpha-amylase release and adenosine 3',5'-monophosphate accumulation in rat parotid tissue slices.
    Butcher FR; Goldman JA; Nemerovski
    Biochim Biophys Acta; 1975 May; 392(1):82-94. PubMed ID: 164957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of thyroid hormone on regulation of lipolysis and adenosine 3',5'-monophosphate metabolism in 3T3-L1 adipocytes.
    Elks ML; Manganiello VC
    Endocrinology; 1985 Sep; 117(3):947-53. PubMed ID: 2410243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bradykinin-dependent activation of adenylate cyclase activity and cyclic AMP accumulation in tracheal smooth muscle occurs via protein kinase C-dependent and -independent pathways.
    Stevens PA; Pyne S; Grady M; Pyne NJ
    Biochem J; 1994 Jan; 297 ( Pt 1)(Pt 1):233-9. PubMed ID: 8280104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stimulation of mammalian adenylate cyclase activity with guanosine 5'-tetraphosphate and other guanine nucleotides.
    Ignarro LJ; Gross RA
    Biochim Biophys Acta; 1978 Jun; 541(2):170-80. PubMed ID: 667124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism.
    Ahn HS; Eardley D; Watkins R; Prioli N
    Biochem Pharmacol; 1986 Apr; 35(7):1113-21. PubMed ID: 2421728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective and full beta 1-adrenoceptor agonist action of a catechol derivative of denopamine (T-0509) in the guinea-pig cardiac muscle and trachea: comparison with denopamine, xamoterol and isoprenaline.
    Yabana H; Watanabe H; Narita H; Nagao T
    Br J Pharmacol; 1992 Jun; 106(2):335-41. PubMed ID: 1356559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of partially purified NSILA on adenylate cyclase, phosphodiesterase and 3',5'-cyclic AMP in fat cells.
    Hepp KD; Renner R; Langley J; Häring HU
    Mol Cell Endocrinol; 1975 Oct; 3(4):309-21. PubMed ID: 172393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular characterization of the pharmacological selectivity and tachyphylactic properties of denopamine for the human beta adrenergic receptors.
    Suzuki T; Nantel F; Bonin H; Valiquette M; Bouvier M
    J Pharmacol Exp Ther; 1993 Nov; 267(2):785-90. PubMed ID: 7902433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.